Literature DB >> 15856312

The Alport nephropathy: clinicopathological correlations.

Richard H R White1, Faro Raafat, David V Milford, Filadelfia Komianou, Nadeem E Moghal.   

Abstract

The alleged dominance of diffuse attenuation of the glomerular basement membrane (GBM) in young children and females with Alport's Syndrome (AS) suggests that it might be the initial ultrastructural manifestation of type IV collagen defects. We carried out a 'blind' review of 130 renal biopsies obtained from 100 patients with AS, emphasizing the electron microscopy changes, and related the findings to the clinical presentation and outcome. The intracapillary distribution of (1) thickened, (2) attenuated and (3) normal GBM was assessed individually as: none (grade 0), <25% (grade 1), 25-50% (grade 2) and >50% (grade 3). Deafness was defined as persistent loss of > or =30 dBs. Proteinuria was measured as protein/creatinine ratios in early morning urine. Heavy proteinuria (> or =200 mg/mmol) correlated significantly with the presence of segmental and global glomerulosclerosis and foam cells. Comparing grades 0+1 vs. 3 GBM changes, using a 2x2 chi(2) test, there were significant correlations between grade 3 GBM thickening and male sex (P =0.005), heavy proteinuria (P =0.02) and deafness (P <0.001). GBM thickening did not correlate with age at the initial biopsy, but repeat biopsies demonstrated increasing thickening with age. The grades of GBM attenuation did not correlate with either age at biopsy or sex. In 11 biopsies with atypical lamina densa changes in thickened GBM segments, there were no differences in clinicopathological correlations compared with classical biopsies. Our data indicate that diffuse GBM attenuation can be an ultrastructural variant of the Alport nephropathy, but do not support the contention that it is the initial lesion.

Entities:  

Mesh:

Year:  2005        PMID: 15856312     DOI: 10.1007/s00467-005-1955-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  32 in total

1.  Two novel alternatively spliced 9-bp exons in the COL4A5 gene.

Authors:  P H Martin; K Tryggvason
Journal:  Pediatr Nephrol       Date:  2001-01       Impact factor: 3.714

Review 2.  Alport syndrome.

Authors:  C E Kashtan; A F Michael
Journal:  Kidney Int       Date:  1996-11       Impact factor: 10.612

3.  Evolution of glomerular basement membrane lesions in a male patient with Alport syndrome: ultrastructural and morphometric study.

Authors:  A M Cangiotti; A Sessa; M Meroni; R Montironi; M Ragaiolo; V Mambelli; S Cinti
Journal:  Nephrol Dial Transplant       Date:  1996-09       Impact factor: 5.992

4.  A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.

Authors:  G J Schwartz; G B Haycock; C M Edelmann; A Spitzer
Journal:  Pediatrics       Date:  1976-08       Impact factor: 7.124

5.  Pathologic characteristics of hereditary nephritis.

Authors:  J Churg; R L Sherman
Journal:  Arch Pathol       Date:  1973-06

6.  Ocular signs in Alport's syndrome.

Authors:  S M Thompson; J P Deady; H E Willshaw; R H White
Journal:  Eye (Lond)       Date:  1987       Impact factor: 3.775

7.  Alport's syndrome: experience at Hôpital Necker.

Authors:  R Habib; M C Gubler; N Hinglais; L H Noël; D Droz; M Levy; P Mahieu; J M Foidart; D Perrin; E Bois; J P Grünfeld
Journal:  Kidney Int Suppl       Date:  1982-05       Impact factor: 10.545

8.  Characteristic ultrastructural lesion of the glomerular basement membrane in progressive hereditary nephritis (Alport's syndrome).

Authors:  N Hinglais; J P Grünfeld; E Bois
Journal:  Lab Invest       Date:  1972-11       Impact factor: 5.662

9.  Renal biopsy diagnosis in children presenting with haematuria.

Authors:  A I Piqueras; R H White; F Raafat; N Moghal; D V Milford
Journal:  Pediatr Nephrol       Date:  1998-06       Impact factor: 3.714

10.  Abnormally thin glomerular basement membranes associated with hematuria, proteinuria or renal failure in adults.

Authors:  F E Dische; M J Weston; V Parsons
Journal:  Am J Nephrol       Date:  1985       Impact factor: 3.754

View more
  5 in total

1.  Evidence-based practice guideline for the treatment of CKD.

Authors: 
Journal:  Clin Exp Nephrol       Date:  2009-12       Impact factor: 2.801

2.  Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold.

Authors:  Roman David Bülow; Peter Boor
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

3.  The effect of progressive glomerular disease on megalin-mediated endocytosis in the kidney.

Authors:  Lotte Vinge; George E Lees; Rikke Nielsen; Clifford E Kashtan; Anne Bahr; Erik I Christensen
Journal:  Nephrol Dial Transplant       Date:  2010-03-02       Impact factor: 5.992

4.  Osteopontin deficiency ameliorates Alport pathology by preventing tubular metabolic deficits.

Authors:  Wen Ding; Keyvan Yousefi; Stefania Goncalves; Bradley J Goldstein; Alfonso L Sabater; Amy Kloosterboer; Portia Ritter; Guerline Lambert; Armando J Mendez; Lina A Shehadeh
Journal:  JCI Insight       Date:  2018-03-22

Review 5.  An update on the pathomechanisms and future therapies of Alport syndrome.

Authors:  Damien Noone; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2012-08-18       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.